Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2018, Article ID 2547098, 14 pages
https://doi.org/10.1155/2018/2547098
Review Article

Three-Dimensional Bioreactor Technologies for the Cocultivation of Human Mesenchymal Stem/Stromal Cells and Beta Cells

1Institute of Bioprocess Engineering and Pharmaceutical Technology, University of Applied Sciences Mittelhessen, Wiesenstraße 14, 35390 Giessen, Germany
2Department of Chemical Engineering, Kansas State University, Manhattan, KS, USA
3Project Group Bioresources, Fraunhofer Institute for Molecular Biology and Applied Ecology (IME), Winchesterstr. 3, 35394 Giessen, Germany

Correspondence should be addressed to Peter Czermak; ed.mht.esl@kamrezc.retep

Received 29 September 2017; Accepted 31 December 2017; Published 14 March 2018

Academic Editor: Ioannis Papantoniou

Copyright © 2018 Florian Petry et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. WHO, Global Report On Diabetes, WHO Press, Geneva, Switzerland, 2017.
  2. P. Tsasis, J. Wu, A. An et al., “Conceptualizing type 2 diabetes and its management,” Journal of Multidisciplinary Healthcare, vol. 9, pp. 133–136, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. W. Siegenthaler and B. R. Amann-Vesti, “Klinische Pathophysiologie,” Thieme, 2006. View at Google Scholar
  4. P. A. Lysy, E. Corritore, and E. M. Sokal, “New insights into diabetes cell therapy,” Current Diabetes Reports, vol. 16, no. 5, p. 38, 2016. View at Publisher · View at Google Scholar · View at Scopus
  5. J. R. Benthuysen, A. C. Carrano, and M. Sander, “Advances in β cell replacement and regeneration strategies for treating diabetes,” The Journal of Clinical Investigation, vol. 126, no. 10, pp. 3651–3660, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Zang, H. Hao, J. Liu, Y. Li, W. Han, and Y. Mu, “Mesenchymal stem cell therapy in type 2 diabetes mellitus,” Diabetology & Metabolic Syndrome, vol. 9, no. 1, p. 36, 2017. View at Publisher · View at Google Scholar · View at Scopus
  7. M. L. Weiss and D. L. Troyer, “Stem cells in the umbilical cord,” Stem Cell Reviews, vol. 2, no. 2, pp. 155–162, 2006. View at Publisher · View at Google Scholar
  8. J. P. McGuirk, J. R. Smith, C. L. Divine, M. Zuniga, and M. L. Weiss, “Wharton’s jelly-derived mesenchymal stromal cells as a promising cellular therapeutic strategy for the management of graft-versus-host disease,” Pharmaceuticals, vol. 8, no. 2, pp. 196–220, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Deuse, M. Stubbendorff, K. Tang-Quan et al., “Immunogenicity and immunomodulatory properties of umbilical cord lining mesenchymal stem cells,” Cell Transplantation, vol. 20, no. 5, pp. 655–667, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. K. H. Yoo, I. K. Jang, M. W. Lee et al., “Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues,” Cellular Immunology, vol. 259, no. 2, pp. 150–156, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. S. J. Prasanna, D. Gopalakrishnan, S. R. Shankar, and A. B. Vasandan, “Pro-inflammatory cytokines, IFNγ and TNFα, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially,” PLoS One, vol. 5, no. 2, article e9016, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. M. L. Weiss, C. Anderson, S. Medicetty et al., “Immune properties of human umbilical cord Wharton’s jelly-derived cells,” Stem Cells, vol. 26, no. 11, pp. 2865–2874, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. T. J. Bartosh, J. H. Ylöstalo, A. Mohammadipoor et al., “Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 31, pp. 13724–13729, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Ren, X. Zhao, L. Zhang et al., “Inflammatory cytokine-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression,” The Journal of Immunology, vol. 184, pp. 2321–2328, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. A. I. Caplan and J. E. Dennis, “Mesenchymal stem cells as trophic mediators,” Journal of Cellular Biochemistry, vol. 98, no. 5, pp. 1076–1084, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. W. G. Gunn, A. Conley, L. Deininger, S. D. Olson, D. J. Prockop, and C. A. Gregory, “A crosstalk between myeloma cells and marrow stromal cells stimulates production of DKK1 and interleukin-6: a potential role in the development of lytic bone disease and tumor progression in multiple myeloma,” Stem Cells, vol. 24, no. 4, pp. 986–991, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Ohtaki, J. H. Ylostalo, J. E. Foraker et al., “Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 38, pp. 14638–14643, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. R. H. Lee, A. A. Pulin, M. J. Seo et al., “Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6,” Cell Stem Cell, vol. 5, no. 1, pp. 54–63, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. C. L. Elseberg, J. Leber, D. Salzig et al., “Microcarrier-based expansion process for hMSCs with high vitality and undifferentiated characteristics,” The International Journal of Artificial Organs, vol. 35, no. 2, pp. 93–161, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. B. Keymeulen, P. Gillard, C. Mathieu et al., “Correlation between β cell mass and glycemic control in type 1 diabetic recipients of islet cell graft,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 46, pp. 17444–17449, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. J. W. Haycock, “3D cell culture: a review of current approaches and techniques,” Methods in Molecular Biology, vol. 695, pp. 1–15, 2011. View at Publisher · View at Google Scholar
  22. J. Lee, M. J. Cuddihy, and N. A. Kotov, “Three-dimensional cell culture matrices: state of the art,” Tissue Engineering Part B: Reviews, vol. 14, no. 1, pp. 61–86, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. L. G. Griffith and M. A. Swartz, “Capturing complex 3D tissue physiology in vitro,” Nature Reviews. Molecular Cell Biology, vol. 7, no. 3, pp. 211–224, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. X. Yin, B. E. Mead, H. Safaee, R. Langer, J. M. Karp, and O. Levy, “Engineering stem cell organoids,” Cell Stem Cell, vol. 18, no. 1, pp. 25–38, 2016. View at Publisher · View at Google Scholar · View at Scopus
  25. A. B. Bernard, C.-C. Lin, and K. S. Anseth, “A microwell cell culture platform for the aggregation of pancreatic β-cells,” Tissue Engineering Part C: Methods, vol. 18, no. 8, pp. 583–592, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. B. R. Lee, J. W. Hwang, Y. Y. Choi et al., “In situ formation and collagen-alginate composite encapsulation of pancreatic islet spheroids,” Biomaterials, vol. 33, no. 3, pp. 837–845, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Amin, K. Ramachandran, S. J. Williams, A. Lee, L. Novikova, and L. Stehno-Bittel, “A simple, reliable method for high-throughput screening for diabetes drugs using 3D β-cell spheroids,” Journal of Pharmacological and Toxicological Methods, vol. 82, pp. 83–89, 2016. View at Publisher · View at Google Scholar · View at Scopus
  28. E. S. O'Sullivan, A. S. Johnson, A. Omer, J. Hollister-Lock et al., “Rat islet cell aggregates are superior to islets for transplantation in microcapsules,” Diabetologia, vol. 53, no. 5, pp. 937–945, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. M. W. Laschke and M. D. Menger, “Life is 3D: boosting spheroid function for tissue engineering,” Trends in Biotechnology, vol. 35, no. 2, pp. 133–144, 2017. View at Publisher · View at Google Scholar · View at Scopus
  30. M. F. Pittenger, A. M. Mackay, S. C. Beck et al., “Multilineage potential of adult human mesenchymal stem cells,” Science, vol. 284, no. 5411, pp. 143–147, 1999. View at Publisher · View at Google Scholar · View at Scopus
  31. K. Mcintosh, S. Zvonic, S. Garrett et al., “The immunogenicity of human adipose-derived cells: temporal changes in vitro,” Stem Cells, vol. 24, no. 5, pp. 1246–1253, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Sart, A.-C. Tsai, Y. Li, and T. Ma, “Three-dimensional aggregates of mesenchymal stem cells: cellular mechanisms, biological properties, and applications,” Tissue Engineering Part B: Reviews, vol. 20, no. 5, pp. 365–380, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. T. Ma, A.-C. Tsai, and Y. Liu, “Biomanufacturing of human mesenchymal stem cells in cell therapy: influence of microenvironment on scalable expansion in bioreactors,” Biochemical Engineering Journal, vol. 108, pp. 44–50, 2016. View at Publisher · View at Google Scholar · View at Scopus
  34. J. H. Ylostalo, T. J. Bartosh, A. Tiblow, and D. J. Prockop, “Unique characteristics of human mesenchymal stromal/progenitor cells pre-activated in 3-dimensional cultures under different conditions,” Cytotherapy, vol. 16, no. 11, pp. 1486–1500, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. T. J. Bartosh, J. H. Ylöstalo, N. Bazhanov, J. Kuhlman, and D. J. Prockop, “Dynamic compaction of human mesenchymal stem/precursor cells into spheres self-activates caspase-dependent IL1 signaling to enhance secretion of modulators of inflammation and immunity (PGE2, TSG6, and STC1),” Stem Cells, vol. 31, pp. 2443–2456, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. J. H. Ylöstalo, T. J. Bartosh, K. Coble, and D. J. Prockop, “Human mesenchymal stem/stromal cells cultured as spheroids are self-activated to produce prostaglandin E2 that directs stimulated macrophages into an anti-inflammatory phenotype,” Stem Cells, vol. 30, no. 10, pp. 2283–2296, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. P. R. Baraniak and T. C. McDevitt, “Scaffold-free culture of mesenchymal stem cell spheroids in suspension preserves multilineage potential,” Cell and Tissue Research, vol. 347, no. 3, pp. 701–711, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. R.-Z. Lin, R.-Z. Lin, and H.-Y. Chang, “Recent advances in three-dimensional multicellular spheroid culture for biomedical research,” Biotechnology Journal, vol. 3, no. 9-10, pp. 1172–1184, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. P. Wuchter, J. Boda-Heggemann, B. K. Straub et al., “Processus and recessus adhaerentes: giant adherens cell junction systems connect and attract human mesenchymal stem cells,” Cell and Tissue Research, vol. 328, no. 3, pp. 499–514, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. E. J. Lee, S. J. Park, S. K. Kang et al., “Spherical bullet formation via E-cadherin promotes therapeutic potency of mesenchymal stem cells derived from human umbilical cord blood for myocardial infarction,” Molecular Therapy, vol. 20, pp. 1424–1433, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. R. Peng, X. Yao, B. Cao, J. Tang, and J. Ding, “The effect of culture conditions on the adipogenic and osteogenic inductions of mesenchymal stem cells on micropatterned surfaces,” Biomaterials, vol. 33, no. 26, pp. 6008–6019, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. P. R. Baraniak, M. T. Cooke, R. Saeed, M. A. Kinney, K. M. Fridley, and T. C. McDevitt, “Stiffening of human mesenchymal stem cell spheroid microenvironments induced by incorporation of gelatin microparticles,” Journal of the Mechanical Behavior of Biomedical Materials, vol. 11, pp. 63–71, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. M. S. STEINBERG, “On the mechanism of tissue reconstruction by dissociated cells, I. Population kinetics, differential adhesiveness, and the absence of directed migration,” Proceedings of the National Academy of Sciences of the United States of America, vol. 48, no. 9, pp. 1577–1582, 1962. View at Publisher · View at Google Scholar
  44. B. M. de Souza, A. P. Bouças, F. D. Oliveira et al., “Effect of co-culture of mesenchymal stem/stromal cells with pancreatic islets on viability and function outcomes: a systematic review and meta-analysis,” Islets, vol. 9, no. 2, pp. 30–42, 2017. View at Publisher · View at Google Scholar · View at Scopus
  45. A. Scuteri, E. Donzelli, V. Rodriguez-Menendez et al., “A double mechanism for the mesenchymal stem cells’ positive effect on pancreatic islets,” PLoS One, vol. 9, no. 1, article e84309, 2014. View at Publisher · View at Google Scholar · View at Scopus
  46. Y. Jun, A. R. Kang, J. S. Lee et al., “Microchip-based engineering of super-pancreatic islets supported by adipose-derived stem cells,” Biomaterials, vol. 35, no. 17, pp. 4815–4826, 2014. View at Publisher · View at Google Scholar · View at Scopus
  47. B. C. Heng, J. Li, A. K.-L. Chen et al., “Translating human embryonic stem cells from 2-dimensional to 3-dimensional cultures in a defined medium on laminin- and vitronectin-coated surfaces,” Stem Cells and Development, vol. 21, no. 10, pp. 1701–1715, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. D. Salzig, A. Schmiermund, P. P. Grace, C. Elseberg, C. Weber, and P. Czermak, “Enzymatic detachment of therapeutic mesenchymal stromal cells grown on glass carriers in a bioreactor,” The Open Biomedical Engineering Journal, vol. 7, no. 1, pp. 147–158, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. Q. A. Rafiq, K. Coopman, A. W. Nienow, and C. J. Hewitt, “Systematic microcarrier screening and agitated culture conditions improves human mesenchymal stem cell yield in bioreactors,” Biotechnology Journal, vol. 11, no. 4, pp. 473–486, 2016. View at Publisher · View at Google Scholar · View at Scopus
  50. J. Leber, J. Barekzai, M. Blumenstock, B. Pospisil, D. Salzig, and P. Czermak, “Microcarrier choice and bead-to-bead transfer for human mesenchymal stem cells in serum-containing and chemically defined media,” Process Biochemistry, vol. 59, pp. 255–265, 2017. View at Publisher · View at Google Scholar · View at Scopus
  51. A. J. Bone and I. Swenne, “Microcarriers: a new approach to pancreatic islet cell culture,” In Vitro, vol. 18, no. 2, pp. 141–148, 1982. View at Publisher · View at Google Scholar · View at Scopus
  52. C. Mantovani Mda, M. M. da Conceição, A. J. Ferreira et al., “Immobilization of primary cultures of insulin-releasing human pancreatic cells,” Islets, vol. 1, no. 3, pp. 224–231, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. S. Del Guerra, C. Bracci, K. Nilsson et al., “Entrapment of dispersed pancreatic islet cells in CultiSpher-S macroporous gelatin microcarriers: preparation, in vitro characterization, and microencapsulation,” Biotechnology and Bioengineering, vol. 75, no. 6, pp. 741–744, 2001. View at Publisher · View at Google Scholar · View at Scopus
  54. M. Hamid, J. T. McCluskey, N. H. McClenaghan, and P. R. Flatt, “Culture and function of electrofusion-derived clonal insulin-secreting cells immobilized on solid and macroporous microcarrier beads,” Bioscience Reports, vol. 20, no. 3, pp. 167–176, 2000. View at Publisher · View at Google Scholar · View at Scopus
  55. P. Gupta, L. Geris, F. P. Luyten, and I. Papantoniou, “An integrated bioprocess for the expansion and chondrogenic priming of human periosteum-derived progenitor cells in suspension bioreactors,” Biotechnology Journal, vol. 13, no. 2, article 1700087, 2018. View at Publisher · View at Google Scholar · View at Scopus
  56. J. L. Wilson and T. C. McDevitt, “Stem cell microencapsulation for phenotypic control, bioprocessing, and transplantation,” Biotechnology and Bioengineering, vol. 110, no. 3, pp. 667–682, 2013. View at Publisher · View at Google Scholar · View at Scopus
  57. M. Mota, J. A. Teixeira, and A. Yelshin, “Immobilized particles in gel matrix-type porous media. Homogeneous porous media model,” Biotechnology Progress, vol. 17, no. 5, pp. 860–865, 2001. View at Publisher · View at Google Scholar · View at Scopus
  58. B. L. Strand, A. E. Coron, and G. Skjak-Braek, “Current and future perspectives on alginate encapsulated pancreatic islet,” Stem Cells Translational Medicine, vol. 6, no. 4, pp. 1053–1058, 2017. View at Publisher · View at Google Scholar · View at Scopus
  59. D. Pipeleers and B. Keymeulen, “Boost for alginate encapsulation in beta cell transplantation,” Trends in Endocrinology & Metabolism, vol. 27, no. 5, pp. 247-248, 2016. View at Publisher · View at Google Scholar · View at Scopus
  60. D. Freimark, P. Pino-Grace, S. Pohl et al., “Use of encapsulated stem cells to overcome the bottleneck of cell availability for cell therapy approaches,” Transfusion Medicine and Hemotherapy, vol. 37, no. 2, pp. 3–73, 2010. View at Publisher · View at Google Scholar · View at Scopus
  61. S. Sart, S. N. Agathos, Y. Li, and T. Ma, “Regulation of mesenchymal stem cell 3D microenvironment: from macro to microfluidic bioreactors,” Biotechnology Journal, vol. 11, no. 1, pp. 43–57, 2016. View at Publisher · View at Google Scholar · View at Scopus
  62. N. A. Silva, J. Moreira, S. Ribeiro-Samy et al., “Modulation of bone marrow mesenchymal stem cell secretome by ECM-like hydrogels,” Biochimie, vol. 95, no. 12, pp. 2314–2319, 2013. View at Publisher · View at Google Scholar · View at Scopus
  63. E. C. Stucky, R. S. Schloss, M. L. Yarmush, and D. I. Shreiber, “Alginate micro-encapsulation of mesenchymal stromal cells enhances modulation of the neuro-inflammatory response,” Cytotherapy, vol. 17, no. 10, pp. 1353–1364, 2015. View at Publisher · View at Google Scholar · View at Scopus
  64. V. Vaithilingam, M. D. M. Evans, D. M. Lewy, P. A. Bean, S. Bal, and B. E. Tuch, “Co-encapsulation and co-transplantation of mesenchymal stem cells reduces pericapsular fibrosis and improves encapsulated islet survival and function when allografted,” Scientific Reports, vol. 7, no. 1, article 10059, 2017. View at Publisher · View at Google Scholar · View at Scopus
  65. S. Jung, K. M. Panchalingam, R. D. Wuerth, L. Rosenberg, and L. A. Behie, “Large-scale production of human mesenchymal stem cells for clinical applications,” Biotechnology and Applied Biochemistry, vol. 59, no. 2, pp. 106–120, 2012. View at Publisher · View at Google Scholar · View at Scopus
  66. M. M. Bonab, K. Alimoghaddam, F. Talebian, S. H. Ghaffari, A. Ghavamzadeh, and B. Nikbin, “Aging of mesenchymal stem cell in vitro,” BMC Cell Biology, vol. 7, no. 1, p. 14, 2006. View at Publisher · View at Google Scholar · View at Scopus
  67. S. Bork, S. Pfister, H. Witt et al., “DNA methylation pattern changes upon long-term culture and aging of human mesenchymal stromal cells,” Aging Cell, vol. 9, no. 1, pp. 54–63, 2010. View at Publisher · View at Google Scholar · View at Scopus
  68. A. Stolzing, N. Coleman, and A. Scutt, “Glucose-induced replicative senescence in mesenchymal stem cells,” Rejuvenation Research, vol. 9, no. 1, pp. 31–35, 2006. View at Publisher · View at Google Scholar · View at Scopus
  69. M. R. Kreke and A. S. Goldstein, “Hydrodynamic shear stimulates osteocalcin expression but not proliferation of bone marrow stromal cells,” Tissue Engineering, vol. 10, no. 5-6, pp. 780–788, 2004. View at Publisher · View at Google Scholar · View at Scopus
  70. F. Zhao, R. Chella, and T. Ma, “Effects of shear stress on 3-D human mesenchymal stem cell construct development in a perfusion bioreactor system: experiments and hydrodynamic modeling,” Biotechnology and Bioengineering, vol. 96, no. 3, pp. 584–595, 2007. View at Publisher · View at Google Scholar · View at Scopus
  71. F. G. Teixeira, K. M. Panchalingam, R. Assunção-Silva et al., “Modulation of the mesenchymal stem cell secretome using computer-controlled bioreactors: impact on neuronal cell proliferation, survival and differentiation,” Scientific Reports, vol. 6, no. 1, article 27791, 2016. View at Publisher · View at Google Scholar · View at Scopus
  72. C. Elseberg, J. Leber, T. Weidner, and P. Czermak, “The challenge of human mesenchymal stromal cell expansion: current and prospective answers,” in New Insights Into Cell Culture Technology, S. J. T. Gowder, Ed., INTECH, Rijeka, Croatia - EUROPEAN UNION. View at Publisher · View at Google Scholar
  73. A. C. Schnitzler, A. Verma, D. E. Kehoe et al., “Bioprocessing of human mesenchymal stem/stromal cells for therapeutic use: current technologies and challenges,” Biochemical Engineering Journal, vol. 108, pp. 3–13, 2016. View at Publisher · View at Google Scholar · View at Scopus
  74. C. J. Hewitt, K. Lee, A. W. Nienow, R. J. Thomas, M. Smith, and C. R. Thomas, “Expansion of human mesenchymal stem cells on microcarriers,” Biotechnology Letters, vol. 33, no. 11, pp. 2325–2335, 2011. View at Publisher · View at Google Scholar · View at Scopus
  75. M. Serra, C. Brito, M. F. Q. Sousa et al., “Improving expansion of pluripotent human embryonic stem cells in perfused bioreactors through oxygen control,” Journal of Biotechnology, vol. 148, no. 4, pp. 208–215, 2010. View at Publisher · View at Google Scholar · View at Scopus
  76. V. Jossen, C. Schirmer, D. Mostafa Sindi et al., “Theoretical and practical issues that are relevant when scaling up hMSC microcarrier production processes,” Stem Cells International, vol. 2016, Article ID 4760414, 15 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  77. G. Pattappa, H. K. Heywood, J. D. Bruijn, and D. A. Lee, “The metabolism of human mesenchymal stem cells during proliferation and differentiation,” Journal of Cellular Physiology, vol. 226, no. 10, pp. 2562–2570, 2011. View at Publisher · View at Google Scholar · View at Scopus
  78. C. Weber, D. Freimark, R. Pörtner et al., “Expansion of human mesenchymal stem cells in a fixed-bed bioreactor system based on non-porous glass carrier – Part B: modeling and scale-up of the system,” The International Journal of Artificial Organs, vol. 33, no. 11, pp. 782–795, 2010. View at Google Scholar
  79. T. A. Grein, J. Leber, M. Blumenstock et al., “Multiphase mixing characteristics in a microcarrier-based stirred tank bioreactor suitable for human mesenchymal stem cell expansion,” Process Biochemistry, vol. 51, no. 9, pp. 1109–1119, 2016. View at Publisher · View at Google Scholar · View at Scopus
  80. R. Olmer, A. Lange, S. Selzer et al., “Suspension culture of human pluripotent stem cells in controlled, stirred bioreactors,” Tissue Engineering Part C: Methods, vol. 18, no. 10, pp. 772–784, 2012. View at Publisher · View at Google Scholar · View at Scopus
  81. C. Weber, S. Pohl, R. Poertner et al., “Production process for stem cell based therapeutic implants: expansion of the production cell line and cultivation of encapsulated cells,” Advances in Biochemical Engineering/Biotechnology, vol. 123, pp. 143–162, 2010. View at Publisher · View at Google Scholar · View at Scopus
  82. P. Czermak, R. Pörtner, and A. Brix, “Special engineering aspects,” in Cell and Tissue Reaction Engineering, M. Fussenegger and W. Weber, Eds., pp. 83–172, Springer Berlin Heidelberg, Berlin, Heidelberg.
  83. C. Weber, D. Freimark, R. Pörtner et al., “Expansion of human mesenchymal stem cells in a fixed-bed bioreactor system based on non-porous glass carrier – Part A: inoculation, cultivation, and cell harvest procedures,” The International Journal of Artificial Organs, vol. 33, no. 8, pp. 512–525, 2010. View at Publisher · View at Google Scholar
  84. M. J. Osiecki, T. D. Michl, B. Kul Babur et al., “Packed bed bioreactor for the isolation and expansion of placental-derived mesenchymal stromal cells,” PLoS One, vol. 10, no. 12, article e0144941, 2015. View at Publisher · View at Google Scholar · View at Scopus
  85. C. Lechanteur, “Large-scale clinical expansion of mesenchymal stem cells in the GMP-compliant, closed automated quantum® cell expansion system: comparison with expansion in traditional T-flasks,” Journal of Stem Cell Research & Therapy, vol. 4, no. 08, 2014. View at Publisher · View at Google Scholar
  86. A. Mizukami, A. Neto, M. S. de et al., “A fully-closed and automated hollow fiber bioreactor for clinical-grade manufacturing of human mesenchymal stem/stromal cells,” Stem Cell Reviews and Reports, vol. 14, no. 1, pp. 141–143, 2018. View at Publisher · View at Google Scholar · View at Scopus
  87. M. Haack-Sørensen, B. Follin, M. Juhl et al., “Culture expansion of adipose derived stromal cells. A closed automated quantum cell expansion system compared with manual flask-based culture,” Journal of Translational Medicine, vol. 14, no. 1, p. 319, 2016. View at Publisher · View at Google Scholar · View at Scopus
  88. T. Lambrechts, I. Papantoniou, B. Rice, J. Schrooten, F. P. Luyten, and J. M. Aerts, “Large-scale progenitor cell expansion for multiple donors in a monitored hollow fibre bioreactor,” Cytotherapy, vol. 18, no. 9, pp. 1219–1233, 2016. View at Publisher · View at Google Scholar · View at Scopus
  89. A.-C. Tsai, Y. Liu, and T. Ma, “Expansion of human mesenchymal stem cells in fibrous bed bioreactor,” Biochemical Engineering Journal, vol. 108, pp. 51–57, 2016. View at Publisher · View at Google Scholar · View at Scopus
  90. M. Guvendiren and J. A. Burdick, “Stiffening hydrogels to probe short- and long-term cellular responses to dynamic mechanics,” Nature Communications, vol. 3, no. 1, article 792, 2012. View at Publisher · View at Google Scholar · View at Scopus
  91. S. Li, S. Kuddannaya, Y. J. Chuah, J. Bao, Y. Zhang, and D. Wang, “Combined effects of multi-scale topographical cues on stable cell sheet formation and differentiation of mesenchymal stem cells,” Biomaterials Science, vol. 5, no. 10, pp. 2056–2067, 2017. View at Publisher · View at Google Scholar · View at Scopus
  92. H. Tanaka, S. Tanaka, K. Sekine et al., “The generation of pancreatic β-cell spheroids in a simulated microgravity culture system,” Biomaterials, vol. 34, no. 23, pp. 5785–5791, 2013. View at Publisher · View at Google Scholar · View at Scopus
  93. G. J. Rogers, M. N. Hodgkin, and P. E. Squires, “E-cadherin and cell adhesion: a role in architecture and function in the pancreatic islet,” Cellular Physiology and Biochemistry, vol. 20, pp. 987–994, 2007. View at Publisher · View at Google Scholar · View at Scopus
  94. A. C. Hauge-Evans, P. E. Squires, S. J. Persaud, and P. M. Jones, “Pancreatic beta-cell-to-beta-cell interactions are required for integrated responses to nutrient stimuli: enhanced Ca2+ and insulin secretory responses of MIN6 pseudoislets,” Diabetes, vol. 48, no. 7, pp. 1402–1408, 1999. View at Publisher · View at Google Scholar · View at Scopus
  95. H. Ishihara, T. Asano, K. Tsukuda et al., “Pancreatic beta cell line MIN6 exhibits characteristics of glucose metabolism and glucose-stimulated insulin secretion similar to those of normal islets,” Diabetologia, vol. 36, no. 11, pp. 1139–1145, 1993. View at Publisher · View at Google Scholar · View at Scopus
  96. M. J. Luther, A. Hauge-Evans, K. L. A. Souza et al., “MIN6 β-cell–β-cell interactions influence insulin secretory responses to nutrients and non-nutrients,” Biochemical and Biophysical Research Communications, vol. 343, no. 1, pp. 99–104, 2006. View at Publisher · View at Google Scholar · View at Scopus
  97. G. Niu, J. P. McQuilling, Y. Zhou, E. C. Opara, G. Orlando, and S. Soker, “In vitro proliferation of porcine pancreatic islet cells for β-cell therapy applications,” Journal of Diabetes Research, vol. 2016, Article ID 5807876, 8 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  98. P. Buchwald, “FEM-based oxygen consumption and cell viability models for avascular pancreatic islets,” Theoretical Biology and Medical Modelling, vol. 6, no. 1, p. 5, 2009. View at Publisher · View at Google Scholar · View at Scopus
  99. B. A. Wagner, S. Venkataraman, and G. R. Buettner, “The rate of oxygen utilization by cells,” Free Radical Biology and Medicine, vol. 51, no. 3, pp. 700–712, 2011. View at Publisher · View at Google Scholar · View at Scopus
  100. K. K. Papas, A. Pisania, H. Wu, G. C. Weir, and C. K. Colton, “A stirred microchamber for oxygen consumption rate measurements with pancreatic islets,” Biotechnology and Bioengineering, vol. 98, no. 5, pp. 1071–1082, 2007. View at Publisher · View at Google Scholar · View at Scopus
  101. W. Wang, L. Upshaw, D. M. Strong, R. P. Robertson, and J. Reems, “Increased oxygen consumption rates in response to high glucose detected by a novel oxygen biosensor system in non-human primate and human islets,” Journal of Endocrinology, vol. 185, no. 3, pp. 445–455, 2005. View at Publisher · View at Google Scholar · View at Scopus
  102. Z. Li, H. Sun, J. Zhang, H. Zhang, F. Meng, and Z. Cui, “Development of in vitro 3D TissueFlex® islet model for diabetic drug efficacy testing,” PLoS One, vol. 8, no. 8, article e72612, 2013. View at Publisher · View at Google Scholar · View at Scopus
  103. J. Daoud, L. Rosenberg, and M. Tabrizian, “Pancreatic islet culture and preservation strategies: advances, challenges, and future outlook,” Cell Transplantation, vol. 19, no. 12, pp. 1523–1535, 2010. View at Publisher · View at Google Scholar · View at Scopus
  104. L. P. Rutzky, S. Bilinski, M. Kloc et al., “Microgravity culture condition reduces immunogenicity and improves function of pancreatic islets1,” Transplantation, vol. 74, no. 1, pp. 13–21, 2002. View at Publisher · View at Google Scholar
  105. H. E. Murray, M. B. Paget, and R. Downing, “Preservation of glucose responsiveness in human islets maintained in a rotational cell culture system,” Molecular and Cellular Endocrinology, vol. 238, no. 1-2, pp. 39–49, 2005. View at Publisher · View at Google Scholar · View at Scopus
  106. L. Samuelson and D. A. Gerber, “Improved function and growth of pancreatic cells in a three-dimensional bioreactor environment,” Tissue Engineering Part C: Methods, vol. 19, no. 1, pp. 39–47, 2013. View at Publisher · View at Google Scholar · View at Scopus
  107. M. Mel, M. I. A. Karim, S. A. M. Yusuf, Y. Z. H.-Y. Hashim, and Y. Ahmad Nor, “Comparing BRIN-BD11 culture producing insulin using different type of microcarriers,” Cytotechnology, vol. 62, no. 5, pp. 423–430, 2010. View at Publisher · View at Google Scholar · View at Scopus
  108. M. Chawla, C. A. Bodnar, A. Sen, M. S. Kallos, and L. A. Behie, “Production of islet-like structures from neonatal porcine pancreatic tissue in suspension bioreactors,” Biotechnology Progress, vol. 22, no. 2, pp. 561–567, 2006. View at Publisher · View at Google Scholar · View at Scopus
  109. L. T. Lock, S. G. Laychock, and E. S. Tzanakakis, “Pseudoislets in stirred-suspension culture exhibit enhanced cell survival, propagation and insulin secretion,” Journal of Biotechnology, vol. 151, no. 3, pp. 278–286, 2011. View at Publisher · View at Google Scholar · View at Scopus
  110. C. A. Hoesli, M. Luu, and J. M. Piret, “A novel alginate hollow fiber bioreactor process for cellular therapy applications,” Biotechnology Progress, vol. 25, no. 6, pp. 1740–1751, 2009. View at Publisher · View at Google Scholar · View at Scopus
  111. S. I. Gundersen, G. Chen, H. M. Powell, and A. F. Palmer, “Hemoglobin regulates the metabolic and synthetic function of rat insulinoma cells cultured in a hollow fiber bioreactor,” Biotechnology and Bioengineering, vol. 107, no. 3, pp. 582–592, 2010. View at Publisher · View at Google Scholar · View at Scopus
  112. N. Nikravesh, S. C. Cox, M. J. Ellis, and L. M. Grover, “Encapsulation and fluidization maintains the viability and glucose sensitivity of beta-cells,” ACS Biomaterials Science & Engineering, vol. 3, no. 8, pp. 1750–1757, 2017. View at Publisher · View at Google Scholar · View at Scopus
  113. F. W. Pagliuca and D. A. Melton, “How to make a functional β-cell,” Development, vol. 140, no. 12, pp. 2472–2483, 2013. View at Publisher · View at Google Scholar · View at Scopus
  114. L. Goers, P. Freemont, and K. M. Polizzi, “Co-culture systems and technologies: taking synthetic biology to the next level,” Journal of the Royal Society, Interface, vol. 11, no. 96, p. 20140065, 2014. View at Publisher · View at Google Scholar · View at Scopus
  115. S. J. Bidarra, C. C. Barrias, M. A. Barbosa, R. Soares, J. Amédée, and P. L. Granja, “Phenotypic and proliferative modulation of human mesenchymal stem cells via crosstalk with endothelial cells,” Stem Cell Research, vol. 7, no. 3, pp. 186–197, 2011. View at Publisher · View at Google Scholar · View at Scopus
  116. A. Pisania, G. C. Weir, J. J. O'Neil et al., “Quantitative analysis of cell composition and purity of human pancreatic islet preparations,” Laboratory Investigation, vol. 90, no. 11, pp. 1661–1675, 2010. View at Publisher · View at Google Scholar · View at Scopus
  117. F. A. Saleh, M. Whyte, and P. G. Genever, “Effects of endothelial cells on human mesenchymal stem cell activity in a three-dimensional in vitro model,” European Cells and Materials, vol. 22, pp. 242–257, 2011. View at Publisher · View at Google Scholar
  118. Y. Tachida, H. Sakurai, and J. Okutsu, “Proteomic comparison of the secreted factors of mesenchymal stem cells from bone marrow, adipose tissue and dental pulp,” Journal of Proteomics & Bioinformatics, vol. 8, no. 12, 2015. View at Publisher · View at Google Scholar